Search

Your search keyword '"Diabetic Nephropathies urine"' showing total 1,750 results

Search Constraints

Start Over You searched for: Descriptor "Diabetic Nephropathies urine" Remove constraint Descriptor: "Diabetic Nephropathies urine"
1,750 results on '"Diabetic Nephropathies urine"'

Search Results

1. Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes.

2. Urinary cyclophilin A as an early marker of chronic kidney disease with underlying type 2 diabetes.

3. Alterations of urine microRNA-7977/G6PD level in patients with diabetic kidney disease and its association with dysfunction of albumin-induced autophagy in proximal epithelial tubular cells.

4. Association of different obesity indexes with diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study.

5. Practicalities and importance of assessing urine albumin excretion in type 2 diabetes: A cutting-edge update.

6. Simultaneous detection of multiple urinary biomarkers in patients with early-stage diabetic kidney disease using Luminex liquid suspension chip technology.

7. Urinary biomarkers NG AL and beta-2 microglobulin in children with type 1 diabetes mellitus.

8. Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis.

9. Application of Proteomics and Machine Learning Methods to Study the Pathogenesis of Diabetic Nephropathy and Screen Urinary Biomarkers.

10. Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.

11. A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.

12. Urinary biomarkers in diabetic nephropathy.

13. Urine biomarkers in type 2 diabetes mellitus with or without microvascular complications.

14. Comparative Analysis of Protein Quantification by the SomaScan Assay versus Orthogonal Methods in Urine from People with Diabetic Kidney Disease.

15. A meta-analysis of urinary transferrin for early diagnosis of diabetic nephropathy.

16. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.

17. Plasma type IV collagen levels as a potential biomarker for early detection of nephropathy in diabetes mellitus patients.

19. Is the urinary neutrophil gelatinase-associated lipocalin concentration in children and adolescents with type 1 diabetes mellitus different from that in healthy children?

20. Urinary sphingolipids in adolescents and young adults with youth-onset diabetes.

21. Isocitrate dehydrogenase 1 upregulation in urinary extracellular vesicles from proximal tubules of type 2 diabetic rats.

22. A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes.

23. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.

24. Ultrasensitive CCL2 Detection in Urine for Diabetic Nephropathy Diagnosis Using a WS 2 -Based Plasmonic Biosensor.

25. Urinary peptide analysis to predict the response to blood pressure medication.

26. URINARY EXCRETION OF ALPHA-ACTININ-4 AND TIGHT JUNCTION PROTEIN 1 IN PATIENTS WITH TYPE 2 DIABETES AND DIFFERENT PATTERNS OF CHRONIC KIDNEY DISEASE.

27. Study of Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 in Patients with Type 2 Diabetes Mellitus Nephropathy.

28. Correlations of cardiovascular autonomic neuropathy with urinary albumin excretion rate and cardiac function in patients with type 2 diabetes mellitus.

29. Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study.

30. Screening candidate diagnostic biomarkers for diabetic kidney disease.

31. Determination of pentoxifylline efficacy on microalbuminuria in patients with type-2 diabetes.

32. Urinary SIRT2 Reflects Kidney Injury in Type 2 Diabetes.

33. Correlation of Urinary Neutrophil Gelatinase with the Histopathological Extent of Kidney Damage in Patients with Diabetic Nephropathy.

34. Designing stimuli-responsive upconversion nanoparticles based on a mimetic immunoassay for potential accurate diabetic nephropathy diagnosis.

35. Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy: The DIAMOND study.

36. Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis.

37. Increased exosomal Calmodulin in the urine of patients with diabetic kidney disease (DKD) may be derived from either CALM1, CALM2, CALM3 or from more than one of these genes.

38. Albuminuria and cardiorenal risk.

39. Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.

40. Effect of Magnesium Status on Microalbuminuria in Type 2 Diabetic Patients.

41. RISK FACTORS FOR DIABETIC NEPHROPATHY IN DIABETES MELLITUS TYPE 1.

42. Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown.

43. [Association study of serum LncRNA MALAT1 and SAA with type 2 diabetic kidney disease].

44. Upregulation of miR145 and miR126 in EVs from Renal Cells Undergoing EMT and Urine of Diabetic Nephropathy Patients.

45. Urinary IgG, serum CX3CL1 and miRNA-152-3p: as predictors of nephropathy in Egyptian type 2 diabetic patients.

46. Urinary interleukin-9 in youth with type 1 diabetes mellitus.

47. Toll-like receptor inflammatory cascade and the development of diabetic kidney disease in children and adolescents with type 1 diabetes.

48. Serum Trimethylamine N-oxide and the Diversity of the Intestinal Microbial Flora in Type 2 Diabetes Complicated by Diabetic Kidney Disease.

49. d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.

50. Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.

Catalog

Books, media, physical & digital resources